Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of MAPKAPK5 polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Rabbit |
| Applications | WB-Ce |
More info about MAPKAPK5 polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB2779 |
| Product name: | MAPKAPK5 polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic peptide of MAPKAPK5. |
| Gene id: | 8550 |
| Gene name: | MAPKAPK5 |
| Gene alias: | PRAK |
| Gene description: | mitogen-activated protein kinase-activated protein kinase 5 |
| Immunogen: | A synthetic peptide (conjugated with KLH) corresponding to residues surrounding T182 of human MAPKAPK5. |
| Protein accession: | NP_003659;Q8IW41 |
| Form: | Liquid |
| Recommend dilutions: | Western Blot (1:1000) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS (0.09% sodium azide) |
| Storage instruction: | Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | Western blot analysis of MAPKAPK5 polyclonal antibody (Cat # PAB2779) in HeLa cell line lysates (35 ug/lane). MAPKAPK5 (arrow) was detected using the purified polyclonal antibody. |
| Applications: | WB-Ce |
| Shipping condition: | Dry Ice |
| Publications: | p62 functions as a p38 MAP kinase regulator.Sudo T, Maruyama M, Osada H. Biochem Biophys Res Commun. 2000 Mar 16;269(2):521-5. |